Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Renal Pelvis and Ureter Urothelial Carcinoma × enfortumab vedotin × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 9 Urinary Bladder Neoplasms 3 Urethral Neoplasms 1 Ureteral Neoplasms 1 Peripheral Nervous System Diseases 1 Neoplasm Metastasis 1 Muscle-invasive Bladder Cancer 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Metastatic Urothelial Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Bladder Cancer 1

Interventions

pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 merphos 1 durvalumab 1 Vinblastine 1 Specimen Handling 1 Platinum 1 Methotrexate 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Gemcitabine 1 Doxorubicin 1 Disulfides 1 Cisplatin 1 Biopsy 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡